{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:30:03Z","timestamp":1792319403709,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amjms.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T04:19:29Z","timestamp":1488946769000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda"],"prefix":"10.1016","volume":"353","author":[{"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna V.R.","family":"Venkata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Jampana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhar-Ul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2017.03.007_bib1","first-page":"219","article-title":"Porphyria cutanea tarda","volume":"vol. 29","author":"Singal","year":"2013"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.007_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda","volume":"18","author":"Elder","year":"1998","journal-title":"Semin Liver Dis"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.007_bib3","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes Porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.007_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Ryan Caballes","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.007_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1013746828074","article-title":"Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C and inherited uroporphyrinogen decarboxylase deficiency","volume":"47","author":"Egger","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.007_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2009.11.017","article-title":"Associations among behavior-related susceptibility factors in porphyria cutanea tarda","volume":"8","author":"Jalil","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.007_bib7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.007_bib8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","article-title":"Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America","volume":"27","author":"Bonkovsky","year":"1998","journal-title":"Hepatology"},{"issue":"4 suppl 2","key":"10.1016\/j.amjms.2017.03.007_bib10","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1097\/01.mcg.0000155517.02468.46","article-title":"Mitochondrial dysfunction in hepatitis C","volume":"39","author":"Korenaga","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.007_bib11","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.22486","article-title":"Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity","volume":"48","author":"Miura","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.007_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10620-007-9945-7","article-title":"Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials","volume":"53","author":"Desai","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.007_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520310000672a","article-title":"Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C","volume":"38","author":"Fernandez","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"27","key":"10.1016\/j.amjms.2017.03.007_bib14","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.4254\/wjh.v7.i27.2740","article-title":"Cutaneous manifestations of hepatitis C in the era of new antiviral agents","volume":"7","author":"Garcovich","year":"2015","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.007_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing and treating adults infected with hepatitis C virus","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"issue":"38","key":"10.1016\/j.amjms.2017.03.007_bib16","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.3748\/wjg.14.5913","article-title":"Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C","volume":"14","author":"Azim","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.007_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2004.10.029","article-title":"Occurrence of porphyria cutanea tarda during peginterferon\/ribavirin therapy for chronic viral hepatitis C","volume":"42","author":"Thevenot","year":"2005","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.007_bib18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1053\/jhep.2002.35072","article-title":"Porphyria cutanea tarda during interferon\/ribavirin therapy for chronic hepatitis C","volume":"36","author":"Jessner","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.007_bib19","first-page":"38","article-title":"Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin","volume":"36","author":"Frider","year":"2006","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.007_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0168-8278(05)80626-9","article-title":"Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C","volume":"21","author":"Di Bisceglie","year":"1994","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.007_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1309\/2GRW-BQ0E-6KYQ-9GMF","article-title":"Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin","volume":"113","author":"Fiel","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.007_bib22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/bjd.13376","article-title":"Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda","volume":"171","author":"Aguilera","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:22:44Z","timestamp":1617236564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917301325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002962917301325"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.03.007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}